An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer

NCT07589569 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: HRS-7058

Sponsor

Shandong Suncadia Medicine Co., Ltd.